Header Logo
Keywords
Last Name
Institution
Announcement

You can now add alternative names! Click here to add other names that you've published under.

Shelley Crary

Concepts (160)

Concept scores are derived automatically based on a person's publications. Keywords in the their attributed publications are matched to keywords from the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). The strength of a person's concept scores is based not only on the number of corresponding publications, but also how relevant the concepts are to the overall topics of the publications, how long ago the publications were written, whether the person was the first or senior author, and how many other people have written about the topic.Concepts cannot be directly edited. You can help ensure your concepts are accurate by making sure your attributed publications are correct and up-to-date. We recommend checking over your attributed publications list every three to four months.

Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Vascular Malformations
7
2023
98
3.410
Why?
Blood Coagulation Disorders
4
2022
33
2.820
Why?
Splenectomy
10
2018
34
1.770
Why?
Spherocytosis, Hereditary
6
2015
14
1.550
Why?
Sclerotherapy
3
2022
45
1.530
Why?
Kasabach-Merritt Syndrome
2
2023
4
1.080
Why?
Hemangioendothelioma
2
2023
7
1.080
Why?
Hemophilia A
2
2024
25
1.040
Why?
Sarcoma, Kaposi
2
2023
72
0.990
Why?
Child
27
2024
6824
0.880
Why?
Child, Preschool
20
2024
3853
0.830
Why?
Anticoagulants
2
2018
254
0.770
Why?
Thrombelastography
1
2020
26
0.740
Why?
Hemostasis
1
2020
55
0.720
Why?
Anemia, Sickle Cell
5
2021
96
0.720
Why?
Sirolimus
2
2023
62
0.710
Why?
Bleomycin
2
2022
35
0.660
Why?
Autoimmune Lymphoproliferative Syndrome
1
2018
2
0.640
Why?
Adolescent
20
2024
6340
0.630
Why?
Antibiotics, Antineoplastic
1
2018
78
0.580
Why?
Purpura, Thrombocytopenic, Idiopathic
3
2024
23
0.560
Why?
Young Adult
11
2024
3936
0.530
Why?
Postoperative Complications
3
2014
1000
0.530
Why?
Hematinics
2
2013
12
0.490
Why?
Reticulocyte Count
2
2015
4
0.490
Why?
Anemia, Iron-Deficiency
2
2013
19
0.490
Why?
Heart Transplantation
1
2018
312
0.470
Why?
Hemorrhage
4
2024
202
0.470
Why?
Humans
36
2024
49827
0.470
Why?
Infant
12
2024
3551
0.430
Why?
Adult
12
2024
13160
0.430
Why?
Hematologic Diseases
2
2009
22
0.420
Why?
Female
21
2024
26329
0.410
Why?
Male
21
2024
25093
0.390
Why?
Ferric Compounds
1
2010
11
0.380
Why?
Hypertension, Pulmonary
1
2011
114
0.350
Why?
Vascular Diseases
2
2009
74
0.340
Why?
Blood Flow Velocity
2
2020
99
0.340
Why?
Retrospective Studies
10
2024
6117
0.340
Why?
Enoxaparin
1
2008
27
0.320
Why?
Thromboembolism
1
2006
54
0.270
Why?
Venous Thrombosis
1
2006
91
0.260
Why?
Osteomyelitis
1
2006
126
0.250
Why?
Cardiovascular Diseases
1
2010
440
0.250
Why?
Prospective Studies
6
2023
2344
0.240
Why?
Hemoglobins
4
2015
108
0.240
Why?
Factor VIII
1
2024
23
0.240
Why?
von Willebrand Diseases
1
2024
22
0.230
Why?
Vascular Neoplasms
1
2023
17
0.230
Why?
Administration, Oral
2
2018
423
0.230
Why?
Anemia, Hemolytic, Congenital
2
2014
4
0.230
Why?
Autoantibodies
1
2024
116
0.220
Why?
Factor IX
1
2023
1
0.220
Why?
Hemophilia B
1
2023
4
0.220
Why?
Critical Illness
2
2020
286
0.220
Why?
Hemangioma
1
2023
83
0.210
Why?
Genetic Therapy
1
2023
114
0.200
Why?
Databases, Factual
2
2024
664
0.200
Why?
Anxiety
1
2024
269
0.200
Why?
Acute Pain
1
2021
8
0.200
Why?
Pupil
1
2021
30
0.200
Why?
Treatment Outcome
5
2022
5138
0.200
Why?
Mental Health
1
2024
216
0.200
Why?
Infusions, Intravenous
3
2013
207
0.200
Why?
Middle Aged
7
2024
11997
0.190
Why?
Arterial Occlusive Diseases
1
2021
81
0.190
Why?
Blood Coagulation Tests
1
2020
19
0.190
Why?
Multiple Organ Failure
1
2020
47
0.180
Why?
Blood Coagulation
1
2020
57
0.180
Why?
Antibodies, Monoclonal, Humanized
1
2021
222
0.170
Why?
Klippel-Trenaunay-Weber Syndrome
1
2019
4
0.170
Why?
Receptors, Fc
1
2019
10
0.170
Why?
Thrombopoietin
1
2019
11
0.170
Why?
Pain
2
2021
380
0.170
Why?
Vitiligo
1
2019
8
0.170
Why?
Depression
1
2024
564
0.160
Why?
Leukoencephalopathies
1
2019
14
0.160
Why?
Autoimmune Diseases of the Nervous System
1
2019
9
0.160
Why?
Nervous System Malformations
1
2019
17
0.160
Why?
Alopecia
1
2019
38
0.160
Why?
Recombinant Fusion Proteins
1
2019
182
0.160
Why?
Fibrin Fibrinogen Degradation Products
1
2018
10
0.160
Why?
Fibrinogen
1
2018
31
0.160
Why?
Skin Neoplasms
1
2023
487
0.160
Why?
Bilirubin
3
2015
40
0.160
Why?
Thrombocytopenia
1
2019
84
0.150
Why?
Autoimmune Diseases
1
2019
100
0.150
Why?
Follow-Up Studies
2
2021
2179
0.140
Why?
Aged
5
2024
9272
0.130
Why?
Cross-Sectional Studies
2
2011
1541
0.130
Why?
Hydroxyurea
1
2015
30
0.130
Why?
Prevalence
2
2024
943
0.130
Why?
Ankyrins
1
2014
9
0.120
Why?
Acute Chest Syndrome
1
2014
8
0.120
Why?
Diagnosis, Differential
1
2018
1036
0.120
Why?
Risk Factors
4
2024
3619
0.120
Why?
Platelet Count
2
2019
72
0.120
Why?
Respiratory Tract Infections
1
2014
75
0.120
Why?
Iron-Dextran Complex
1
2013
3
0.110
Why?
Quality of Life
1
2019
833
0.110
Why?
Hematoma
1
2013
66
0.110
Why?
Protein Precursors
1
2011
43
0.100
Why?
Remission, Spontaneous
1
2011
24
0.100
Why?
Anemia, Hemolytic
1
2011
11
0.100
Why?
Tricuspid Valve
1
2011
21
0.100
Why?
Natriuretic Peptide, Brain
1
2011
30
0.100
Why?
Texas
1
2011
137
0.100
Why?
Early Diagnosis
1
2011
87
0.100
Why?
Glucaric Acid
1
2010
1
0.100
Why?
Infant, Newborn
3
2024
2744
0.090
Why?
Aged, 80 and over
2
2024
3125
0.090
Why?
Blood Cell Count
1
2010
37
0.090
Why?
Cholesterol, LDL
1
2010
34
0.090
Why?
Lipids
1
2010
147
0.090
Why?
C-Reactive Protein
1
2010
142
0.090
Why?
Ultrasonography
1
2011
436
0.090
Why?
Neoplasms
1
2019
1233
0.080
Why?
Medical Audit
1
2008
21
0.080
Why?
Cholesterol
1
2007
146
0.070
Why?
Acute Disease
1
2006
369
0.060
Why?
Thrombosis
1
2007
249
0.060
Why?
Terminology as Topic
1
2024
63
0.060
Why?
Vincristine
1
2023
89
0.060
Why?
Disease Management
1
2024
174
0.050
Why?
Genetic Vectors
1
2023
127
0.050
Why?
Ambulatory Care Facilities
1
2023
125
0.050
Why?
Alleles
1
2023
251
0.050
Why?
Genetic Testing
1
2023
116
0.050
Why?
Sclerosing Solutions
1
2022
14
0.050
Why?
Registries
2
2015
518
0.050
Why?
Educational Status
1
2023
222
0.050
Why?
P-Selectin
1
2021
32
0.050
Why?
Analgesics
1
2021
101
0.050
Why?
Pain Measurement
1
2021
236
0.050
Why?
Intensive Care Units, Pediatric
1
2020
168
0.040
Why?
United States
2
2024
4838
0.040
Why?
Clinical Trials as Topic
1
2021
460
0.040
Why?
Disease Susceptibility
1
2019
89
0.040
Why?
Time Factors
2
2019
2912
0.040
Why?
Incidence
1
2021
1003
0.040
Why?
Disease-Free Survival
1
2019
457
0.040
Why?
Length of Stay
1
2020
623
0.040
Why?
Survival Rate
1
2019
905
0.030
Why?
Immunosuppressive Agents
1
2018
220
0.030
Why?
Therapeutic Equivalency
1
2015
7
0.030
Why?
Solutions
1
2015
24
0.030
Why?
Capsules
1
2015
30
0.030
Why?
Antisickling Agents
1
2015
13
0.030
Why?
Decision Making
1
2018
262
0.030
Why?
Reticulocytes
1
2014
9
0.030
Why?
Physicians
1
2018
234
0.030
Why?
Risk Assessment
1
2019
1262
0.030
Why?
Forehead
1
2013
8
0.030
Why?
Molecular Weight
1
2013
84
0.030
Why?
Laparoscopy
1
2015
173
0.030
Why?
Syndrome
1
2011
234
0.020
Why?
Hemolysis
1
2009
27
0.020
Why?
Thrombocytosis
1
2007
4
0.020
Why?
Polycythemia
1
2007
9
0.020
Why?
Wounds and Injuries
1
2009
284
0.020
Why?
Crary's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
_
Co-Authors Expand Description
_
Similar People Expand Description
_
Same Department Expand Description